Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-12-08

FDA Approved: EPIDUO — Original Application (Galderma Laboratories, L.P.)

View source ↗

Summary

FDA approved Epiduo, a fixed-dose combination of adapalene and benzoyl peroxide, for the treatment of acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPIDUO (adapalene and benzoyl peroxide)

Snippet

ORIG AP for EPIDUO (ADAPALENE AND BENZOYL PEROXIDE)